WOODBURY, NY, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Research Frontiers Inc. (Nasdaq: REFR) highlighted the strong industry interest in SPD-SmartGlass at last week’s ECV Automotive Glazing Summit in Detroit, where Research Frontiers President & CEO Joseph M. Harary served as Chairman of the event and delivered the keynote address. The summit brought together automakers, Tier-1 suppliers, glass manufacturers, and technology innovators to discuss next-generation automotive glazing and its role in vehicle comfort, ...

Core Insights - CytoDyn Inc. is set to present clinical data at the San Antonio Breast Cancer Symposium, showcasing sustained remission in patients with metastatic triple-negative breast cancer (mTNBC) following treatment with leronlimab and immune checkpoint inhibitors [1][3] Company Overview - CytoDyn is a clinical-stage oncology company focused on advancing leronlimab, a first-in-class humanized monoclonal antibody targeting the CCR5 receptor, with potential applications in various cancers, including mTNBC and colorectal cancer [1][6] Clinical Data Presentation - Dr. Milana V. Dolezal from Stanford University will present a poster detailing the prolonged survival of mTNBC patients treated with leronlimab in combination with PD-L1/PD-1 immune checkpoint inhibitors, highlighting the upregulation of PD-L1 levels [2][9] - The poster presentation is scheduled for December 12, 2025, from 12:30 PM to 2:00 PM CST at the Exhibit Hall [9] Treatment Efficacy - The use of leronlimab has been associated with increased PD-L1 levels, which may enhance the efficacy of immune checkpoint inhibitors in mTNBC patients, particularly those with low PD-L1 expression [2][3]

Core Points - Digital Ally, Inc. announced the full lineup for the 2026 Country Stampede Music Festival, featuring headliners Treaty Oak Revival, Zach Top, and Rascal Flatts [1][2] - The festival aims to showcase both established artists and emerging talent, with a diverse support lineup including Wyatt Flores, Scotty McCreery, and others [3] - The event will take place on June 25, 26, and 27, 2026, at the Azura Amphitheater in Bonner Springs, Kansas, with various ticketing options available [6] Group 1 - The 2026 Country Stampede will include a pre-party and late-night after parties to enhance fan experiences [4] - An annual Battle of the Bands competition will allow rising artists to compete for a chance to open the Main Stage [5] - Kustom Entertainment emphasizes community engagement and aims to provide a platform for emerging artists alongside established headliners [6] Group 2 - Digital Ally, Inc. operates through subsidiaries engaged in video solution technology, healthcare revenue cycle management, and event production [7] - Kustom Entertainment, a subsidiary of Digital Ally, specializes in producing live entertainment experiences, with the Country Stampede being a flagship event [7]

Core Viewpoint - Wrap Technologies, Inc. has announced that the Rio Grande City Police Department in Texas will implement the BolaWrap® 150 device and the WrapReady™ program to enhance non-lethal response capabilities amid increasing operational pressures along the U.S.–Mexico border [1][4]. Group 1: Agreement Details - The agreement includes full WrapReady onboarding for 12 officers, covering equipment, multi-year support, and instructor-level certification, marking the first deployment in a Texas border community [2]. - The WrapReady program aims to reduce friction in deployment, training, and long-term utilization of the BolaWrap® ecosystem, focusing on safer engagements and continuous development of agency tactics and policy [4][5]. Group 2: Operational Context - Rio Grande City is located in a high-traffic area of the U.S.-Mexico border, where local agencies frequently engage in multi-jurisdictional operations related to narcotics interdiction, human smuggling, and mental health crises, necessitating non-lethal response tools [3]. - The adoption of the WrapReady program reflects a national trend among law enforcement agencies re-evaluating pain-compliance tools and opting for non-lethal options like BolaWrap as first-resort tools in complex encounters [4]. Group 3: Product Overview - Wrap Technologies offers a comprehensive public safety portfolio, including the BolaWrap 150 device, WrapReality™ training platform, and WrapVision™ body-worn camera system, all designed to enhance public safety and operational efficiency [6][7]. - The BolaWrap 150 is a non-pain-based compliance tool that helps officers manage non-compliant subjects without resorting to higher-force options, thereby reducing injury risks [9].

Core Insights - Profusa, Inc. is set to present a Late Breaking Clinical Trial Update on its Lumee™ Oxygen tissue monitoring platform at the Paris Vascular Insights (PVI) 2025 conference, highlighting its innovative technology for continuous monitoring of tissue oxygen in patients with peripheral artery disease [1][2] - The Lumee technology allows for real-time measurement of tissue oxygen levels directly within the body, representing a significant advancement in biochemistry monitoring for both clinical and home use [2][3] - Profusa aims to provide personalized biochemical data through its long-lasting, injectable biosensors, which are designed to deliver actionable medical-grade information for both personal and medical applications [3] Presentation Details - The presentation titled "Monitoring Tissue Oxygen Dynamics with a Novel Implantable Hydrogel Sensor in Patients with Peripheral Arterial Disease (PAD)" will be delivered by Dr. Peter Schneider on December 13, 2025, at 1pm CET [2] - The event will take place at the Carrousel du Louvre in Paris, France, showcasing the latest innovations in vascular and endovascular surgery [2] Company Overview - Profusa is based in Berkeley, California, and is recognized for its pioneering work in developing tissue-integrated sensors that continuously transmit reliable biochemical data [3] - The company is led by a team of experienced professionals and aims to create a new generation of affordable biosensors that enhance patient care through personalized data [3]

Core Insights - BioCardia, Inc. has appointed Farhan Shahab as Vice President of Quality, bringing over 25 years of experience in executive roles related to quality and regulatory affairs [1][2]. Company Overview - BioCardia is a global leader in cellular and cell-derived therapeutics aimed at treating cardiovascular and pulmonary diseases [1][3]. - The company has two main biotherapeutic platforms: CardiAMP® (autologous cell therapy) and CardiALLO™ (allogeneic cell therapy), with three clinical stage product candidates currently in development [3]. Leadership and Expertise - Farhan Shahab previously held significant roles at Welldoc, Intuity Medical, Moximed, and AngioScore, focusing on quality assurance and regulatory compliance [2]. - Shahab's expertise in product quality management and regulatory submissions is expected to enhance BioCardia's ability to commercialize its investigational products [3].

Core Viewpoint - Alpha Modus, Corp. has filed two patent infringement lawsuits against V-Count Global Holding Ltd. and Stratacache, Inc. to protect its core patents related to retail technology and shopper behavior analytics [1][4][5] Patent Infringement Lawsuits - The lawsuits are filed in the Eastern District of Texas and the Central District of California, asserting infringement of patents that are foundational to Alpha Modus' retail intelligence technologies [1][4][5] - The patents in question include U.S. Patent Nos. 10,853,825; 10,977,672; 11,042,890; 11,049,120; 11,301,880; 12,026,731; 12,039,550; 12,354,121; and 12,423,718, which cover various aspects of shopper behavior analytics and store operations [4][5][8] Technology and Development - Alpha Modus has developed its patented systems over more than a decade, focusing on real-world retail applications rather than litigation [3][9] - The company's technologies include real-time customer analytics, inventory management, and personalized marketing, which are integral to modern retail operations [7][10][11] Ecosystem and Market Position - The company emphasizes the importance of enforcing its patents to maintain a fair and standardized ecosystem in the retail technology industry [3][9] - Alpha Modus is expanding its commercial and licensing footprint, with plans for national sales expansion in 2026 [10]

Core Points - Canacol Energy Ltd. has filed for relief under Chapter 15 of the U.S. Bankruptcy Code to protect its U.S.-based assets and facilitate cooperation with foreign judicial proceedings [1][2] - The company is seeking recognition of its Canadian proceeding under the Companies' Creditors Arrangement Act (CCAA) as a foreign main proceeding [1][2] - A hearing on the recognition motion is scheduled for December 11, 2025, after provisional relief was granted by the U.S. Bankruptcy Court [3] Company Overview - Canacol Energy Ltd. is a natural gas exploration and production company primarily operating in Colombia [4] - The company's shares are traded on multiple exchanges, including the Toronto Stock Exchange, OTCQX in the U.S., and the Bolsa de Valores de Colombia [4]

Core Insights - Nanox's AI solutions, HealthOST and HealthVCF, have been recommended for use in UK NHS hospitals for three years as part of an evaluation of AI in bone disease detection [1][2][3] - The National Institute for Health and Care Excellence (NICE) has included these solutions in an Early Value Assessment to gather evidence on their effectiveness in detecting vertebral fragility fractures [2][3] - The AI technologies aim to enhance the detection of vertebral fragility fractures through opportunistic detection in X-ray images and CT scans [3] Company Overview - Nanox.AI is a subsidiary of Nanox focused on deep-learning medical imaging analytics, targeting chronic and acute diseases [6] - The company aims to drive the transition to preventive healthcare by providing affordable medical imaging technologies [7] - Nanox's ecosystem includes various components such as Nanox.ARC, Nanox.AI, Nanox.CLOUD, and Nanox.MARKETPLACE, all designed to improve early detection and treatment [8] Product Details - HealthOST and HealthVCF utilize existing CT scans to support early detection of bone diseases without additional imaging or radiation exposure [4] - These solutions are integrated with existing PACS workflows, allowing real-time identification of clinically significant findings [5] - The tools are expected to improve patient outcomes by enabling timely preventive interventions for conditions like osteoporosis [5]

Core Insights - Bridger Aerospace has announced a strategic acquisition of two Canadair CL-215T Amphibious Aircraft, increasing its Super Scooper fleet from six to eight aircraft, thereby solidifying its position as the owner of the largest private Super Scooper fleet globally [1][2][4] Company Overview - Bridger Aerospace Group Holdings, Inc. is one of the largest aerial firefighting companies in the United States, providing services to federal and state government agencies, including the U.S. Forest Service [5] - The company is based in Belgrade, Montana, and operates internationally [5] Acquisition Details - The acquisition involves a $50 million transaction for the two Super Scoopers, expected to close before the end of the year, subject to customary closing conditions [2] - This expansion is anticipated to enhance the company's ability to combat severe wildfires and better serve government agency partners [2][4] Operational Impact - With the addition of the two aircraft, Bridger Aerospace is positioned for expanded contract awards and increased mission capability heading into the 2026 fire season [4] - The company is also working on returning two additional Super Scooper aircraft to service at its Spanish subsidiary, Albacete Aero, with completion scheduled for 2026 [3]